Precision Medicine in Patients With Unresectable CholAngiocarcinoma: RadioEmbolization and Combined Biological Therapy

NCT06375915 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Intrahepatic Cholangiocarcinoma

Interventions

RADIATION: radioembolization with Y-90
DRUG: Durvalumab
DRUG: Cisplatin
DRUG: Gemcitabine

Sponsor

Francesco De Cobelli

Collaborators

[object Object]
[object Object]
[object Object]